[Lithium carbonate in prevention of leukopenia/caused by antineoplastic drugs].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control*; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy
D000970:Antineoplastic Agents; D016651:Lithium Carbonate; D008094:Lithium
Il carbonato di litio nella prevenzione della leucopenia indotta da farmaci antiblastici.